All articles tagged with #trading halt
The New York Stock Exchange experienced a technical glitch that caused significant disruptions, including showing Berkshire Hathaway's stock down nearly 100%. The issue, related to industry-wide price bands, was resolved before noon Eastern time. Other affected stocks included Barrick Gold, while trading in Berkshire's B-class shares and on rival Nasdaq remained normal.
The New York Stock Exchange resolved a technical issue that caused significant price fluctuations for about 50 stocks, including Berkshire Hathaway, which was incorrectly shown to fall 99%. The issue, linked to a software update, was fixed by reverting to an older data center, and normal trading resumed late Monday morning.
The New York Stock Exchange resolved a technical glitch that caused major stocks, including Berkshire Hathaway, to show drastically incorrect prices, with Berkshire appearing to drop 99.97%. The issue, not caused by a cyberattack, was linked to industry-wide price bands. Trading has since resumed normally.
Trading of Intercept Pharmaceuticals' common stock has been halted as the FDA's Gastrointestinal Drugs Advisory Committee reviews obeticholic acid as a treatment for pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of June 22, 2023, for the review of the New Drug Application (NDA) for obeticholic acid. Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.
Bitcoin traded around $28,000 as concerns about financial stability fueled bets that major central banks will need to stop increasing rates amid rising recession anxiety. Binance, the world's largest cryptocurrency exchange, halted all spot trading on its platform due to a technical glitch, but its derivatives platform was unaffected. Other tokens were lower, with Ether down 2.4% and altcoins Cardano and Solana both down around 2.5%.